Author: david

Open data: what and why

  Presentation by Dr. Elena Giglia on Open Data given on October 10th in the European Parliament in Brussels at the event organized by TACD “Why European academics and researchers want open access”.   EU OPEN DATA GIGLIA

Worrisome EU proposal on clinical trials

Deregulation proposal that affects our medicines and health: Less dependable data, fewer safety requirements and little transparency. Proposal for a Regulation of the European Parliament and of the Council on Clinical Trials on Medicinal Products for Human Use, and Repealing…

Open Access event in the European Parliament

MEPs Luigi Berlinguer (S&D)    Ioannis A. Tsoukalas (EPP) and Philippe Lamberts (Greens/EFA)   Why Europe’s researchers and academics want a clear open access policy in Horizon 2020. In the next few months the European Parliament will decide its position on…

Píldoras amargas de la mala ciencia farmacéutica

Los medicamentos no son testados mediante ensayos experimentales por equipos científicos independientes que tienen una única vocación de hacer prevalecer los valores epistemológicos del conocimiento y la búsqueda de verdades sobre sus efectos en el cuerpo y la salud humana.…